No More Eye Injections for Wet Macular Degeneration?

Genetech has formulated Lucentis’ active ingredient into a refillable eye implant that delivers the medication continuously into the eyes of wet macular degeneration patients. Known as the Port Delivery System, the implantable drug has shown promising results in the second phase of clinical studies. The Port Delivery System is slightly bigger than a grain of […]

Visual acuity not maintained with anti-VEGF

A follow-up study was conducted to determine the long-term benefit and visual acuity outcomes of patients undergoing anti-VEGF treatments, such as Eyelea, Lucentis and Avastin. What researchers found was that visual gains were not maintained after 5 years of injections. Records of 647 patients with wet AMD were analyzed in the Comparison of Age-Related Macular […]

Avastin and Lucentis both pose same risk of infection

Doctors who were quick to come the defense of using the much more costly Lucentis to treat macular degeneration rather than its cheaper counterpart Avastin tried to argue that Lucentis had a lower risk of infection. However, a recent study conducted by the University of Pennsylvania found that argumentĀ is not true. In the study, more […]

Avastin more effective for diabetic macular edema

A recent study did a comparison of the three top drugs used to treat diabetic macular edema. Researchers took a look at Avastin, Eylea and Lucentis and while all three drugs were equally effective in improving vision in patients who had slight vision impairment, Eylea was found to be more effective in treating patients with […]

Lucentis gains FDA approval for treating diabetic retinopathy

Earlier this month, the FDA expanded the approved use of Lucentis to include its use in treating diabetic retinopathy in people who have diabetic macular edema. The announcement came after two clinical studies confirmed the drug’s safety and efficacy in treating diabetic retinopathy in diabetic macular edema patients. Patients involved in the study who received […]

Does cost go into macular degeneration prescription decisions?

When it comes to treating the wet form of macular degeneration, there are two drugs that doctors typically consider and while the drugs are equally effective, the cost of each is dramatically different. Researchers decided to examine whether the cost difference between these two had significant bearing upon which drug a doctor prescribed. Ranibizumab was […]

Eylea injections effective when other treatments for wet AMD have failed

A recent study conducted at the University of Iowa revealed that macular degeneration patients benefited from bimonthly injections of Eylea when monthly injections of Avastin or Lucentis failed. The injections are used for patients dealing with the wet form of macular degneration. Thirty-one patients in the study saw a reduction in fluid within their eyes […]

Lucentis slows progression of diabetic retinopathy

A three-year study reveals that a drug used to treat macular degeneration may also be effective in slowing the progression of diabetic retinopathy. The study was conducted at the University of Wisconsin and researchers evaluated the use of Lucentis to help treat diabetic retinopathy. 700 people participated in the study and researchers determined that not […]

Lucentis, a treatment for macular degeneration, may help diabetics too

Lucentis is currently approved to treat wet age-related macular degeneration (AMD) and the Food and Drug Administration is currently considering expanding its approval of Lucentis to treat diabetic macular edema as well. Both wet AMD and diabetic macular edema involve swelling of the macula. It’s estimated that more than 500,000 Americans have diabetic macular edema […]

Intravitreal injections do not raise stroke risk

Avastin and Lucentis continue to be in the spotlight as researchers continue to study the safety of the drugs. A recent study conducted by researchers in Ontario finds that the drugs, when used to treat AMD, do not increase the risk of heart attack or stroke. Previously, the drugs have been found to increase the […]